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Background: Patients with chronic diseases, like diabetes need to continuously perform
tasks associated with self-management especially with medications they use. It is shown
that the patients with diabetes with limited HL and PTHL cannot read medication labels
correctly, may misuse their medications, spend much more on therapy and generally
have difficulties in understanding printed care instructions and perceiving health advice
and warnings. There has been an increasing demand for valid and reliable instruments
for HL and PTHL assessment in this population. This review aims to search and critically
discuss instruments used to assess HL and PTHL in people with type 2 diabetes and
propose their use in different settings.
Methods: Authors conducted a comprehensive, electronic search of original studies
using a structured approach of the Scopus and PubMed databases, during November
and the first 2 weeks of December 2020 to find relevant papers. The review was
conducted in accordance with the Cochrane guidelines and the reporting was based on
the PRISMA-ScR. The comparison of instruments was made by utilizing a comparison
model related to their structure, measurement scope, range, psychometric properties,
validation, strengths, and limitations.
Results: The final number of included studies was 24, extracting the following
identified instruments: Korean Functional Test HL, NVS, FCCHL, HLS-EU-47, TOFLHA,
S-TOFHLA, REALM-R, 3-brief SQ, REALM, HLQ and DNT-15. In all, FCCHL and
3-brief SQ are shown with the broadest measurement scopes. They are quick, easy,
and inexpensive for administration. FCCHL can be considered the most useful and
comprehensive instrument to screen for inadequate HL. The limitation is that the English
version is not validated. Three-brief SQ has many advantages in comparison to other
instruments, including that it is less likely to cause anxiety and shame. These instruments
can be considered the best for measuring functional HL in patients with diabetes mellitus
type 2 and other chronic diseases. PTHL instruments (REALM and DNT-15) did not find
the best application in this population.
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Conclusions: The future research should be directed in validation of the FCCHL in
English and establishing of the structural validity of this questionnaire. Developing a
specific PTHL questionnaire for this population will be of great help in management of
their disease.
Keywords: health literacy, medication literacy, measurement tool, assessment, patient, chronic disease,
healthcare system
INTRODUCTION
The main goal of today’s healthcare system is to promote and
maintain good health and at the same time enable people
to take care of their health. People are also expected to be
more responsible for their health and participate more in
decision-making related to their health (1–3). When we talk
about responsibility for our health, we must consider different
assumptions. Efforts should be focused on a person’s ability to
cope and take responsibility for their health (3). The Patients’
Rights Act from 1999 states that the manner of participation in
healthcare decisions should be adapted to each person’s ability to
give and receive health information. These abilities are related to
health literacy (HL) (4).
To understand and use health information to make health
decisions, adequate HL is needed (4). In a report by the World
Health Organization (WHO), HL is one of the most important
determinants of health. HL can be considered necessary to
control and monitor one’s health (5). Several studies have shown
that most people have limited HL (6–12). Also, people with low
HL are more likely to be with poorer health, more prone to
complications, and have a higher mortality rate than people with
high HL (5).
Healthcare professionals should consider that individuals
possess different levels of HL. Therefore, knowledge about HL
of people is necessary to adapt better health professionals’
communication with different target groups, which would make
the information more beneficial for the individual by enabling
them to participate in health decisions and take responsibility for
their health (13).
Optimizing health communication can prevent
misunderstandings and other complications, thus the quality
of care and patient safety would be improved (13). In order
to meet expectations such as increased participation and
responsibility for one’s health, it is necessary to consider HL in
individuals and the general population. The purpose of today’s
public health policy is to create conditions for educating people
to be able to take control of their health and control it (3).
Therefore, measuring HL in different populations would provide
essential knowledge that would be used to improve health
communication, and thus the ability of individuals to control
their health. However, the validity and reliability of individual
HL instruments have not been adequately established (14) and
only a few HL instruments were validated using modern test
theory, such as Rasch modeling (15, 16).
Health Literacy
Adequate health literacy is crucial for patients to make
optimal choices for their health and medications management.
Additionally, successful health communication presupposes
certain levels of competence of both the healthcare professional
and the patients and is adapted to the HL of the individuals (5).
“HL” as a recognized term came into use around 1974, but only
became a [Medical Subject Headings (MeSH)] term inMEDLINE
in 2006. A systematic review of Sørensen et al. (17) discovered
17 definitions and 12 conceptual models of HL. Based on all the
offered, one overall definition was obtained, which reads: “HL is
linked to literacy and entails people’s knowledge, motivation and
competencies to access, understand, appraise, and apply health
information in order to make judgments and take decisions
in everyday life concerning healthcare, disease prevention and
health promotion to maintain or improve quality of life during
the life course.” There is currently no consensus on defining HL,
which means that different approaches to this term are used in
various research environments (17–20). An additional concept
of understanding becomes a problem when it comes to assessing
and measuring HL and then comparing these results between
different studies (16). The presence of different definitions is
probably due to the fact that the concept has been developed
in different parts of the world, with varying abilities and skills
considered necessary to deal with health information in each
specific context (21).
In the twentieth century, reading and writing were sufficient
to use information obtained from health professionals. However,
with increasing expectations of active participation in health
decisions, increasing responsibility for one’s health, and digital
development in health information, additional skills are needed
to handle health information. First, the need for reading has
increased, and the skills to apply and critically evaluate health
information from various sources are essential. HL combines a
set of skills or abilities, while on the other hand it depends on the
requirements to which the individual is exposed. The impact of
technological development has also increased, which will affect
the definition and understanding of HL in the future (22).
Pharmacotherapy Literacy (PTHL)
Patients with chronic diseases need to continuously perform
tasks associated with self-care and self-management of their
medications. When taking medicines, they constantly need
abilities related to various domains of HL, so HL brings
together many concepts that are associated with patient’s
pharmacotherapy. Whether they rely on information in printed
materials or verbal instruction patients with chronic conditions
need to have adequate HL related to medications as critical for
managing their conditions. Due to the complexity of the various
procedures required for the adequate use of medications, the
concept of PTHL was introduced.
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King and colleagues, in consultation with the academy and
pharmacists, formulated PTHL as: “An individual’s capacity to
obtain, evaluate, calculate, and comprehend basic information
about pharmacotherapy and pharmacy related services necessary
to make appropriate medication-related decisions, regardless of the
mode of content delivery (e.g., written, oral, visual images and
symbols)” (23). This definition was updated by adding to reduce
thereby the risk of poor pharmacotherapy outcomes (24).
HL and PTHL in Persons With Type 2
Diabetes Mellitus
Diabetes is one of the most common chronic non-communicable
diseases and is a major public health problem. In 2019, the
International Diabetes Federation estimated that 463 million
adults worldwide have diabetes and that this number is expected
to increase to 700 million by 2,045. The cause of this disease is
multifactorial, but it is associated with unhealthy lifestyles such
as physical inactivity and poor diet. It is assumed that between
30 and 80% of people with type 2 diabetes are still undiagnosed.
Complications such as diabetic nephropathy and neuropathy
may occur at a later diagnosis of disease (25). Despite advances
in therapy and the availability of clinical practice guides, only
30% of patients manage to achieve the target values of glycemia,
cholesterol and blood pressure. The fact is that patients perform
95% of diabetes care on their own (26).
Type 2 diabetes is more common than type 1, so 90% of all
diabetes is type 2 diabetes. It most often occurs in middle age and
in the elderly. It is closely related to lifestyle and health habits,
with being overweight and obese being risk factors. Hereditary
factors can also influence the risk of developing this disease.
Therapy includes weight loss, diet and therapy with drugs that
lower blood glucose levels. Affected people are advised to give up
cigarettes and reduce alcohol intake to prevent the appearance of
cardiovascular diseases. Living with this disease requires changes
in health behavior, self-control, and a lot of care (27–29). Since
living with type 2 diabetes requires a lot from people with the
disease, these persons must be informed about therapy, diet
and other health behaviours, which require adequate HL and
PTHL. Several international studies have shown that reading and
understanding the guidelines for modern diabetes medications,
applying appropriate dietary restrictions, and gaining insight
into the physiological processes involved in the disease can be
a major challenge for an individual (30, 31). The performing of
diabetes self-management tasks frequently involves abilities, such
as takingmedications at the right time, interpreting blood glucose
levels and calculating insulin doses.
A recent review of HL and health outcomes in patients with
type 2 diabetes concludes that there is strong evidence to suggest
a positive correlation betweenHL and diabetes knowledge (32). It
is also considered that there is sufficient evidence to support a link
between HL and self-care (33). On the other hand, the evidence
of a link betweenHL and clinical indicators was inconsistent (34).
Some primary studies that looked at the level of HL in patients
with type 2 diabetes found that a small number of these patients
had adequate levels of HL (35–39).
Patients with diabetes and limited HL and PTHL often
cannot read drug medication labels correctly, may misuse
their medication, do not understand the meaning of consent
forms, and generally have difficulty understanding printed care
instructions and reading health advice and warnings (40–43). For
this reason, is very important to assess their PTHL and in case of
needs perform adequate training in order to improve control of
their disease and pharmacotherapy management.
These patients also have poorer communication with doctors
and participate less in making health decisions (4). Patients who
are diagnosed have to make health decisions daily and must
also perform complex self-care activities to keep the disease
under control. Interventions in upgrading HL education and
intensive diabetes-related education have shown good results in
patients with limited HL to improve diabetes outcomes (44, 45).
People with type 2 diabetes should undergo diabetes education
programs at the time of diagnosis and then once a year. This
education aims to enable individuals to participate in informed
decision-making and disease control, all with the aim of better
outcomes in treatment of this disease, improvement of glycemic
control, prevention of complications and comorbidities, and
improvement of quality of life (46). Education for diabetics
should be evidence-based, have specific goals, and be tailored
to the needs of individuals. However, the effectiveness of this
education depends on individuals, i.e., characteristics such as age,
gender, ethnicity, level of HL, ability to take care of themselves,
all of which should be taken into account when planning and
implementing this type of education (27, 47). In this way, they
will be able to understand and use the information they receive
to maintain health and control diabetes in everyday life (47).
Instrument Development
In the past 25 years, numerous instruments have been developed
to measure HL and PTHL in various contexts (14, 24, 48).
These instruments significantly differ in structure, measurement,
range, and psychometric properties. The diversity of instruments
has led to inconsistencies in measurement with the complexity
of interpreting the results and choosing suitable instruments
for new studies. Several studies have examined the variation
through the range of the most used HL instruments (49, 50).
Such variations can come from the fact that the instruments
measure different conceptual dimensions of HL. However, it
may be difficult for health professionals or researchers to
choose the best instrument when they are unfamiliar with
measurement properties. Another very important consideration
in selecting a HL instrument is its mode of administration. In
a subjective instrument, individuals self-report their perceived
levels of literacy skills, such as using Likert scales. In contrast, an
objective instrument is the interviewer-administrated instrument
and assesses the ability to process information by asking
respondents to answer specific questions, such as about the time
to take the next medication. A subjective instrument requires
less cognitive effort in responding to questions, whereas an
objective instrument assesses health numeracy more accurately.
A self-administrated instrument can be more practical in a very
busy clinical settings, than interviewer-administered instrument.
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Sometimes, the interviewer-administrated instrument may result
in discomfort or embarrassment for patients who have a low HL.
Although the instruments were used in several populations,
due to the complexity of the tasks and skills that people with
type 2 diabetes require, their usefulness and applicability for this
population remain challenging. With the growing interest in this
construct, there has been an increasing demand for valid and
reliable instruments for estimating HL and PTHL.
A systematic review of measurement properties has been
designed for providing a comprehensive overview of the
available instruments and identifying the best currently available
instrument for general population (51). In the previous reviews of
HL instruments methodological limitations were identified, such
as being descriptive rather than systematic reviews, or lacking
quality assessment or data synthesis (14, 52, 53). To address these
limitations, a scoping review was conducted to systematically
collect the literacy instruments used in people with type 2
diabetes and meet needs for understanding the characteristics,
scope of measurements, and their applicability in this population.
METHODOLOGICAL STUDY DESIGN
Aim
This study aims to analyze instruments used in patients with
type 2 diabetes mellites for measuring HL and PTHL, in
relation to their characteristics (measurement scope, structure,
domains, method of scoring), validation, strengths, limitations
and accordingly to propose applicability of these instruments
in clinical and research settings. This work can be useful as an
inventory for researchers and practitioners who are seeking to
identify validatedmeasurement instruments in patients with type
2 diabetes mellitus and other chronic diseases that are fitting the
best for their research and practice.
Materials and Methods
Authors built a search strategy by using the PICOS questionnaire.
During November and the first 2 weeks of December 2020,
a systematic search of the Scopus and PubMed databases was
performed in search of peer-reviewed literature of patients with
type 2 diabetes mellitus. The protocol of this systematic review
(including the article identification strategy and data collection
form, etc.) mainly referred to the Cochrane Handbook for
Systematic Reviews of Interventions (54) and the reporting of this
systematic review was based on the Preferred Reporting Items for
Systematic Reviews andMeta-analyses (PRISMA) statement (55).
Search Strategy
The keywords used were: “medication literacy,” “measurement
tool,” “assessment,” “patient,” “chronic diseases” and “healthcare
system.” A search of the terms above found that the number of
articles specifically mentioning PTHL was limited, so the search
was extended to articles mentioning “health literacy” combined
with patients with type 2 diabetes.
In the articles obtained by this search, the references were
manually checked to identify additional articles of importance for
the work.
Study Screening and Selection
All original articles in English are taken into consideration,
which meet the below criteria. Duplicates have been excluded.
The evaluation of studies regarding the inclusion and exclusion
criteria was performed by a pair of independent reviewers (ML
and DK): (1) review of titles and abstracts of articles related
to the topic (2) review of complete articles was done which
examined the HL and PTHL of patients with type 2 diabetes and
had the original results of the health and pharmacotherapeutic
literacy of patients with type 2 diabetes mellitus conducted
through appropriate questionnaires. After cross-checking, a third
reviewer (NBS) resolved cases of disagreement.
Inclusion and Exclusion Criteria
Peer-reviewed papers with cross-sectional studies, longitudinal
studies and cohorts were included if they were: published
between the period 2006–2021, written in English, involved
patients with type 2 diabetes and papers in which HL and PTHL
were examined in patients with type 2 diabetes.
The exclusion criteria were: reviews, case reports, book
chapters, letters, editorials, studies that did not address HL and
PTHL among patients with type 2 diabetes, studies that did not
use the questionnaire for assessing literacy, studies not available
or not published in English.
The inclusion and exclusion criteria are presented in Table 1.
Data Extraction and Synthesis of Results
Data extraction was performed independently by the authors.
They extracted different characteristics from each publication,
such as (i) publication information: author and year; (ii)
study characteristics: country, setting, population, number of
participants and results in terms of HL and PTHL (iii) HL
and PTHL instruments: name, dimensions, number of items,
purpose, target population, administration mode, validation
process, scoring, cut-off points, strengths and limitations.
The studies were grouped according to instruments used
for the measurement of literacy: HL and PTHL. A descriptive
synthesis of the identified studies was performed, and variables
described in the synthesis include number of participants, setting,
TABLE 1 | Inclusion and exclusion criteria.
Inclusion criteria Exclusion criteria
Population Patients with type 2
diabetes mellitus
Patients with other diseases
Type of the study Cross-sectional,
longitudinal, Cohort
Reviews, case reports, book
chapters, letters, editorials
Instruments Using the questionnaire for
accessing health/and
pharmacotherapy literacy




Language English Studies not available or not
published in English
Other Availability of abstract
The full text available
Year of publication > 2006
Unavailability of abstract
The full text not available
Year of publication < 2006
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country, population and results. Formal analysis of the results
was a descriptive synthesis of the identified instruments from
selected studies to determine instruments key characteristics
including identifying domains, length of tool (number of
questions/items/domains), time for completion, format, and
psychometric properties.
Critical Appraisal
At the time of our research, there were no accepted quality
assessment instruments for cross-sectional studies (56), authors
decided to choose a relatively widely used scale, the Agency for
Healthcare Research and Quality scale (AHRQ scale) with 11
items, each of which was answered with “yes,” “no” and “unclear.”
Two researchers (DK and ML) independently evaluated the
quality of the included articles using the AHRQ scale. Any
disagreements after cross-checking were resolved by discussions
between the two researchers with the final decisions of the third
researcher (NBS). If the answer was “no,” “unclear” or “not
applicable,” the item was given a score of “0”; if the answer was
“yes,” the item was scored as “1.” The quality assessments of the
articles were classified as follows: low quality = 0–3, medium
quality= 4–7, high quality= 8–11 (57).
The quality assessment of the identified studies is presented
in Table 2. The majority of them were classified with medium
quality and one fulfilled the criteria for high.
RESULTS
Study Screening and Selection
The PRISMA flow chart in Figure 1 summarises the results of the
search process. 1. A search obtained 5,874 potentially relevant
studies, while 8 were found by reference review. A cursory
review of the content of the papers left 356 papers for further
evaluation. Further exclusion (after reading the abstracts and
methodology) was based on the principle of excluding papers
that mentioned the instrument for assessing HL and PTHL, but
without analyzing its structure, and excluding papers that are
duplicates (same author, same instrument) left 111 articles for full
reading, of which the final number of included studies was 24.
The comparison method was used to compare the instrument
in terms of their structure (number and type of questions),
the way of reporting, version, purpose, place where they were
developed, target population, the person who developed it, year
of publication, scoring, heath literacy domains, time and way
for administration, measurement scope, validation, strengths,
and limitations.
A thorough analysis has been presented in the Tables 3–5.
Tables 3, 4 present the instruments used in the studies to assess
HL and PHTL, their basic characteristics: domains, methods
of assignment, structure and method of scoring. Table 5 shows
the psychometric characteristics of the instruments, strengths
and limitations.
Instrument Characteristics
The identified instruments used for assessing the level of HL and
PTHL in extracted works are the following: Korean Functional
Test HL (1 study), Newest Vital Sign, NVS (1 study), Functional,
Communicative and Critical Health Literacy scale, FCCHL (1
study), Health Literacy Survey European Questionnaire 47, HLS-
EU-47 (1 study), Test of Functional Health Literacy in Adults,
TOFLHA (1 study), Test of Functional Health Literacy in Adults–
Short Form, S-TOFHLA (8 studies), Rapid Estimate of Adult
Literacy in Medicine–Revised, REALM-R (1 study), 3 brief
screening questions, 3-brief SQ (6 studies), Rapid Estimate of
Adult Literacy in Medicine, REALM (3 studies), Health Literacy
Questionnaire, HLQ (1 study) and Diabetes Numeracy Test 15,
DNT-15 (1 study) (37, 58–80). There are considerable differences
found in their structure, number of items, administration time,
available languages, type of administration, scoring system,
measurement scope and properties, implicating their use in
different settings.
The most used measures of HL in patients with type 2
diabetes mellitus were S-TOFHLA, then 3-brief SQ, REALM
and HLS-EU-47. The S-TOFHLA, TOFHLA and REALM have
been validated in different populations and are used in validation
studies for 3-brief SQ and NVS. They are considered as a gold
standard in validation studies. However, 3-brief SQ and NVS
have a broader measurement scope and better properties, which
put them in a better position for use in future validation studies.
S-TOFHLA, REALM and HLS-EU-47 are not practical in busy
clinical settings and REALM requires researcher participation.
While the most used instruments, S-TOFHLA and REALM,
measure only the functional domain of HL, the others 3-brief
SQ, and HLQ address functional and critical HL, and DNT-15,
KHLS and TOFHLA functional HL and numeracy. The only one
for examination of all three levels of HL individually, their mutual
correlation and different effects on patient is FCCHL.
Validation, Strengths, and Limitations
NVS - Good reliability and convergent validity with well-
validated and commonly used measures of HL such as the
TOFHLA. Strengths are related to its suitability for rapid
assessment of lowHL. Test format might intimidate respondents.
FCCHL - Strong positive evidence for its content and
structural validity and moderate positive evidence for internal
consistency. This scale includes three levels of HL, each of which
might have different effects on patient outcomes. It is proved to be
easy to administer in a clinical setting. The scale is not validated
in English.
Three-brief SQ - Positive evidence for the criterion validity
of the 3-SQ with the S-TOFHLA (36 items) and limited
negative evidence for its hypothesis testing validity and internal
consistency. Instrument is validated in several diverse sample
populations. It is quick, easy, and inexpensive for administration.
Limitation is related to self-assessment and potential for self-
report bias.
HLS-EU-47 - High levels of internal consistency reliability.
It is available in many languages, length of assessment increases
response burden.
S-TOFHLA - Demonstrated evidence for the internal
consistency due to there being no evidence of structural validity.
It has been validated in several diverse populations. Lack of this
instrument is that it may not capture an individuals’ HL in the
dimension of numeracy.
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TABLE 2 | Critical appraisal of identified studies: quality assessment.
References Questions Quality of
studies
Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11
Klinovszky et al. (58) 1 1 1 1 0 0 0 0 0 1 0 5
medium
Hashim et al. (59) 1 1 1 1 0 0 0 0 0 1 0 5
medium
Gomes et al. (60) 1 1 1 0 0 1 0 0 0 1 0 5
medium
Finbråten (61) 1 0 1 1 0 1 0 0 1 1 0 6
medium
Tseng et al. (62) 1 0 0 1 0 0 0 0 0 1 0 3
low
Friis et al. (63) 1 0 1 1 0 0 0 0 0 1 0 4
medium
Sayah et al. (64) 1 1 1 1 0 1 0 1 1 1 0 8
high
Thurston et al. (65) 1 1 1 1 0 0 0 1 0 1 0 6
medium
Mantwill et al. (66) 1 1 1 1 0 0 0 1 0 1 0 6
medium
van der Heide et al. (67) 1 0 1 1 0 1 0 0 1 1 0 6
medium
Sayah et al. (68) 1 1 1 1 0 0 0 0 0 1 0 5
medium
Bauer et al. (69) 1 0 1 1 0 0 1 0 0 1 0 5
medium
Coffman et al. (70) 1 1 1 1 0 0 0 0 0 1 0 5
medium
McCleary-Jones, (71) 1 1 1 1 0 0 1 0 0 1 0 6
medium
Glasgow et al. (72) 1 1 1 1 0 1 0 0 0 1 0 6
medium
Bains et al. (73) 1 1 1 1 0 1 0 0 0 0 0 5
medium
Mancuso, (74) 1 1 1 1 0 0 0 0 0 1 0 5
medium
Osborn et al. (37) 1 1 1 1 1 1 0 1 0 1 0 8
high
Sarkar et al. (75) 1 1 1 1 0 0 1 1 0 1 0 7
medium
Mbaezue et al. (76) 1 1 1 1 0 0 0 0 0 1 0 5
medium
Kim, (77) 1 1 1 1 0 0 0 0 0 1 0 5
medium
Ishikawa et al. (78) 1 0 1 1 1 0 1 0 0 1 0 6
medium
Gebretsadik et al. (79) 1 1 1 1 0 0 1 1 0 1 0 7
medium
Morris et al. (80) 1 0 1 0 0 1 0 0 0 1 0 4
medium
Q1: Define the source of information (survey, record review) Q2: List inclusion and exclusion criteria for exposed and unexposed subjects (cases and controls) or refer to previous
publications Q3: Indicate time period used for identifying patients Q4: Indicate whether or not subjects were consecutive if not population-based Q5: Indicate if evaluators of subjective
components of study were masked to other aspects of the status of the participants Q6: Describe any assessments undertaken for quality assurance purposes (e.g., test/retest of
primary outcome measurements) Q7: Explain any patient exclusions from analysis Q8: Describe how confounding was assessed and/or controlled Q9: If applicable, explain how missing
data were handled in the analysis Q10: Summarize patient response rates and completeness of data collection Q11: Clarify what follow-up, if any, was expected and the percentage of
patients for which incomplete data or follow-up was obtained.
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FIGURE 1 | Flow diagram for work extraction.
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3-brief SQ Self-reported Short version Self-report of
confidence in HL skills
USA/Adults Chew et al. (49) English
KHLS Objective Original Screening test for




Lee et al. (81) Korean
FCCHL Objective Original Self-report of HL skills Japan/Adults Ishikawa et al. (78) Japanese












Available in more than
10 languages
NVS Objective Original Information presented








TOFHLA Objective Original Close style reading
comprehension of
health-related content
USA/Adults Parker et al. (84) English, Spanish,
Chinese, French,
German and Italian
S-TOFHLA Objective Short version To measure patients’
ability to read and
understand
health-related materials
USA/Adults Baker et al. (85) English, Spanish,
French, German and
Italian
REALM Objective Original A rapid screening tool




USA/Adults Davis et al. (86) English
REALM-R Objective Revised form Word recognition and
pronunciation test
USA/Adults Bass et al. (87) English
HLQ Self-reported Original Survey items for
measuring health
literacy of individuals
Australia/Adults Osborne et al. (88) English
DNT-15 Objective Short version Reading recognition,
spelling, and arithmetic
computation
USA/Adults Huizinga et al. (89) English, Spanish
3-brief SQ, 3 brief screening questions; KHLS, Korean functional Health Literacy Test; FCCHL, Functional, Communicative and Critical Health Literacy scale; HLS-EU-Q4 7, Health
Literacy Survey European Questionnaire47; NVS, Newest Vital Sign; TOFHLA, Test of Functional Health Literacy in Adults; s-TOFHLA, Test of Functional Health Literacy in Adults–Short
Form; REALM, Rapid Estimate of Adult Literacy in Medicine; REALM-R, Rapid Estimate of Adult Literacy in Medicine–Revised; HLQ, Health Literacy Questionnaire; DNT, Diabetes
Numeracy Test.
REALM - Found to have a high test-retest reliability of
0.99. It is assessed by healthcare professionals and was found
to have good face validity; however, it lacks in construct
validity. It is quick and easy for administration, limited to the
ability to pronounce words without being able to measure the
patient’s ability to understand the instructions on labelling of
prescribed drug.
HLQ - Positive moderate evidence for its content validity
and internal consistency and unknown evidence for structural
validity. Strength is that measures multiple domains of HL, but
due to self-assessment has a potential for self-report bias.
DNT - Moderate evidence for its content validity and
internal consistency and limited positive evidence for structural
validity. This is test numeracy that is associated with diabetes
management. Limitation is that can be difficult or require high
numeracy skills (49, 78, 81–89).
Health Literacy and Pharmacotherapy
Literacy
Preliminary data in relation to HL and PTHL were
extracted from the studies included in the qualitative
synthesis and summarized in Table 6 (for HL) and Table 7
(for PTHL).
In the research period most of the studies were published
in the period from 2006 to 2021 (37, 58–80). The largest
number of studies was conducted in the United States (11
studies) and Canada (2 studies). In contrast, in South Korea,
Japan, Switzerland, Taiwan, Spain, Norway, Brazil, Denmark,
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3-brief SQ Values of 0, 1, 2, 3, and 4 are
assigned to each response option for
each question; Score ranges from 0
to 12; High scores = high HL skills;
Low scores = low HL skills
Functional and
critical HL








KHLS Sum score Functional HL and
numeracy







FCCHL Each item is scored on a 4-point
scale ranging from 1 (never) to 4
(often); The scores of the items are
summed up and divided by the
number of the items in the scale.













HLS-EU-Q47 The 47 items are adapted to a
50-point scale: 0–25: inadequate
health literacy. 26–33: problematic
health literacy; 33–42: sufficient
health literacy; 42–50: excellent HL






NVS Each item answered correctly is given
a score of 1. Scores range: 1–6








TOFHLA Scores range 0–100: <60 =
inadequate HP; 60–75 = marginal









S-TOFHLA Scores range 0–36: 0–16 =
inadequate HL; 17–22 = marginal
HL; 23–36 = adequate HL





REALM Grade is assigned based on total
score that ranges from 0 to 66: 0–18
= ≤ 3rd grade, 19–44 = 4th-6th
grade, 45–60 = 7th-8th grade; 61–66
= ≥9th grade





REALM-R Grade is assigned based on total
score that ranges from 0 to 8. Score
≤6 corresponds to 6th grade and
indicates poor HL





HLQ Independent scales that measure










DNT-15 Items are scored as binary outcomes:
correct or incorrect. Scores are
reported as percent correct (with a
possible range of 0% to 100%)
Functional HL and
numeracy






Iraq, Netherlands andHungary, one study was performed. Cross-
sectional studies make up the majority (20 studies), while three
are longitudinal and one is a cohort study. The sample size ranged
from at least 50 to 46,354 subjects and are adults over the age of
(37, 58–80).
In six studies, limited HL was observed in <50% of subjects,
and in five studies, more than 50% of subjects had limited HL.
HL levels have been linked to diabetes knowledge and treatment
efficacy, while HbA1C concentrations, Internet use, glycemic
control, and health consequences have not been linked to HL
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TABLE 5 | Instruments’ validation, sterngts and limitations.
Name of the tool Validation Strengths Limitations
3-brief SQ Tested against STOFHLA, items AUROC
curve ranged from 0.76 to 0.87 (95% CI).
The grouped items, including a fourth item
about verbal information, (BRIEF),
demonstrated an AUROC curve of 0.79
(95% CI) for identifying inadequate skills.
Correlations as grouped items against
S-TOFHLA (0.42) and REALM (0.40) in
multiple demonstrating moderate
correlation.
The instrument is validated in several
diverse sample populations. It is quick,
easy, and inexpensive for administration.
Functional domains associated with
inadequate HL are assessed. Less likely to
induce anxiety and shame.
Methods typically relied on convenience
samples. Self-assessment has potential
for self-report bias.
KHLS The overall fit of the two-factor model of
the scale was assessed by root mean
square error of approximation (0.039),
indicating a good fit (criterion 0.05 or less)
with an internal consistency of 0.89.
Measure uses questionnaire format
containing short passages, pictures, and
graphs with multiple-choice answer
format, providing a skills-based approach
to measurement. Authors used factor
analysis methods for development.
No concurrent validity assessed due to
lack of a comparative instrument. 10% of
study participants needed assistance from
interviewers.
FCCHL Reliability: Cronbach’s α: Overall scale:
0.78; Functional domain: 0.84;
Communicative domain: 0.77; Critical
domain: 0.65
This scale includes three levels of HL,
each of which might have different effects
on patient outcomes. It is proved to be
easy to administer in a clinical setting.
HL was measured based on a
self-reported questionnaire. Individuals
with reading problems are often ashamed
and hide their inability to read, which might
have led to an overestimation of the HL
levels. Not validated in English.
HLS-EU-Q47 Correlated with NVS (0.25). A multivariate
linear regression model with the total
sample measured the relation between
social variables and health literacy yielding
an adjusted R2L17.4%, pL.00. Financial
deprivation was the strongest predictor of
health literacy.
Available in many languages.
Comprehensive, conceptual based
measure of most dimensions of health
literacy.
Self-assessment has potential for
self-report bias. Length of assessment
increases response burden.
NVS Reliability of Cronbach’s alpha in English
(0.76) and on Spanish (0.69) and
correlates with TOFHLA (0.49). The
AUROC curve is 0.88 for the English
version and 0.72 for the Spanish version.
The NVS test is suitable for rapid
assessment of low HL.
Validation sample did not fully represent a
demographically diverse population. Test
format might intimidate respondents.
TOFHLA Reliability: Cronbach’s α: 0.98; Validity:
0.84 (with REALM),.0.74 (with WRAT-R)
It has been validated in several diverse
populations. Available in different
languages.
Long version is time consuming. This
version is more useful as a research tool
than a clinical screening tool.
S-TOFHLA Reliability: Cronbach’s α: 0.98; Validity:
0.91 (with TOFHLA), 0.80 (with REALM)
Short version is available. It has been
validated in several diverse populations.
It may not capture an individuals’ HL in the
dimension of numeracy.
REALM Correlated with WRAT-R2 (r = 0.82)
WRAT-R3, (0.88); SORT-R, (0.95, 0.96);
PIAT-R, (0.94, 0.97); TOHFLA, (0.30,
0.84). Test-retest correlation: test-retest
reliability 0.98 and 0.99.
It is quick and easy for administration. It is
short, can be easily administered with
minimal training, and it’s strongly
correlated with standardized literacy
assessments.
Only measures one dimension of HL.
Limited to the ability to pronounce words
without being able to measure the
patient’s ability to understand the
instructions on labeling of prescribed drug.
REALM-R Reliability: Cronbach’s α: 0.91.
Validity:0.72 (with REALM), 0.64 (with
WRAT-R)
A promising tool for the rapid assessment
of HL in a busy clinical practice to screen
for potential literacy problems.
Only measures one dimension of HL.
Presence of a ceiling effect. Does not
measure the patient’s understanding of the
words.
HLQ A nine-factor model was fit using 44 final
items with no cross-loadings or correlated
residuals. The fit was satisfactory CFI =
0.936 = 0.930, RMSEA = 0.076, and
WRMR = 1.698. Correlations between
factors showed a clear distinction between
the agree/disagree scales, but less
distinction for cannot do/very easy scales.
It measures multiple domains of HL. Self-assessment that has a potential for
self-report bias.
DNT-15 Correlated with REALM (0.54), WRAT
(0.62), and Diabetes Knowledge Test
(0.71); Internal reliability (0.95). It has good
internal reliability (0.90 and 0.89); split
sample analysis, correlated with the full
DNT in both subsamples (0.96 and 0.97).
Tests numeracy is associated with
diabetes management.
Validated in highly educated sample and
resulted in mean score correct of
61%—may be difficult or require high
numeracy skills.
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TABLE 6 | Basic characteristics of the included studies for HL1.
Instrument Coutry Sample size Results References
S-TOFHLA USA 1,002 HL levels have not been associated with glycemic
control or the health consequences of type 2 diabetes
(80)
REALM USA 398 HL levels were not associated with HbA1C blood levels (79)
FCCHL Japan 138 The three HL scales were only moderately correlated
with each other, suggesting that each represents a
different domain of HL abilities and skills.
(78)
KHLS South Korea 103 71.7% of patients had limited HL (77)
S-TOFHLA USA 189 HL was not associated with blood glucose
measurement, but was associated with recording of
glucose measurement
(76)
3-brief SQ USA 14,102 Patients with limited HL were less likely to log on to the
patient portal
(75)
TOFHLA USA 102 36.3% of patients had limited HL (74)
S-TOFHLA USA 250 The level of HL has not been linked to the use of the
Internet
(72)
S-TOFHLA (Spanish) Spain 144 46.5% of patients had limited HL (70)
3-brief SQ USA 1,366 72% of patients had limited HL (69)
3-brief SQ Canada 154 Limited HL has been observed in patients with type 2
diabetes who have also been diagnosed with depression
(68)
3-brief SQ Netherlands 1,714 Lower HL was significantly associated with less diabetes
knowledge, higher HbA1c level, less self-control of
glucose level, and less physical activity
(67)
3-brief SQ (1 question) Switzerland 493 8.7% of patients had limited HL (66)
S-TOFHLA USA 288 32.8% of patients had limited HL (65)
3-brief SQ Canada 1,948 12.6% of patients had limited HL (64)




Even after adjusting socio-demographic characteristics,
people with diabetes and limited HL were more likely to
be physically inactive and had unhealthy eating habits
compared to people with high levels of HL
(63)
NVS Taiwan 232 76.3% of patients had limited HL (62)
HLS-EU-Q47 FCCHL Norway 388 Good general health, education and empowerment were
positively associated with HL in people with T2DM. They
explained about 17% of the total variance in HL
(61)
S-TOFHLA Brazil 347 A significant number of patients did not have adequate
HL
(60)
S-TOFHLA Iraq 280 Most subjects had limited HL and poor glycemic control (59)
levels (37, 58–80). One study found an increased prevalence of
people with limited HL who were diagnosed with depression
(67), while another study found that people with limited HL were
more likely to eat unhealthily and had reduced physical activity
compared to people with high HL (62).
DISCUSSION
This work presents the most comprehensive inventory of HL
and PTHL measures in patients with type 2 diabetes mellites
to date. There are limited number of works assessed the
instruments that measure HL in patients with type 2 diabetes
and they were focused only on available self-administered
instruments in regards of validation aspects (90), however
this work presents the broader perspective including the
more comprehensive report on their structure, measurement
scope, scoring etc. allowing possibilities for clinicians, health
professionals and researchers to evaluate available HL and
PTHL instruments and match them with the goals of
their work.
HL has been presented as ameasurable and important concept
in considering education for patients with chronic diseases such
as diabetes. It has been shown that in comparation to the other
scales that focus exclusively on functional HL, FCCHL covers
all three levels of HL, each of which can have different effects
on patient outcomes. Also, the scale is easy to apply in clinical
conditions (61).
The identified instruments have inherent strengths and
weaknesses as a result of their structure, properties and
measurement scope. The REALM, NVS, TOFHLA/ s-TOFHLA,
DNT, KHLS, FCCHL and NVS are designed to directly measure
specific skills and have some limitations in administration,
especially in clinical settings where they are more likely to
cause anxiety and shame among patients with inadequate HL
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TABLE 7 | Basic characteristics of the included studies for pharmacotherapy literacy.
Instrument Coutry Sample size Results References
S-TOHFLA DNT-15 Hungary 102 34.6% of the patients with T2DM had inadequate/marginal
reading and comprehension level
*(58)
REALM USA 383 The level of HL has been linked to the effectiveness of patient
treatment
(37)
REALM-R USA 125 HL levels have been linked to the level of diabetes knowledge, but
have not been linked to glycaemia or medication
(73)
REALM USA 50 The level of HL has been linked to level of knowledge about
diabetes
(71)
*Accessing both–health and pharmacotherapy literacy.
and PTHL skills. Self-administrated instruments such as 3-
brief SQ, HLS-EU-47 and HLQ non-directly measure certain
skills and they are less likely to cause the anxiety and shame
which makes them more suitable to be used in clinical settings
and research applications. Many self-reported measures are
designed as screening tests that may be differentially sensitive and
specific than measures developed to more fully describe HL for
research or clinical purposes. This is also seen in other articles
(21, 91, 92).
The NVS had good sensitivity and may be more sensitive
than the TOFHLA for marginal HL (83). Using the test can alert
physicians and pharmacists to focus on the patients who require
more attention and help them communicate with those patients
by using recommended techniques.
The REALM and the TOFLHA focus primarily on reading-
related skills and therefore do not present comprehensive
measures for the skills needed by individuals in the healthcare
system (21).
Time of administration plays a significant role in clinical
settings. In this regard 3-brief SQ, NVS, FCCHL, REALM,
REALM-R, S-TOFHLA and HLQ are relatively quick and easy
for an administration and can be considered in different clinical
settings and survey researches.
The type of administration must also be considered for
practicality in clinical settings. REALM, REALM-R, KHLS and
DNT-15 require involvement of the researcher and could cause
shame and discomfort. Since self-administered instruments
TOFHLA, S-TOFHLA, NVS, HLS-EU-47 and HLQ are very
unlikely to cause discomfort, they require good visual abilities,
full concentration, and good writing skills. Three-brief SQ and
FCCHL can be administered in both ways and are more flexible
and convenient for use.
A lack of researches with PTHL questionnaires in patients
with type 2 diabetes mellitus is a very limiting factor for this
population since the use of multiple drugs/insulins is very
common. REALM only measures one dimension of HL and does
not assess the patient’s understanding of the words. DNT-15 is
the test for numeracy.
The findings of this review can be used for other chronic
conditions with similar HL and PTHL demands on individuals.
This review did not only address the usefulness and applicability
of the instruments in individuals with diabetes but also
provided an evaluation of these instruments and their strengths
and weaknesses, which are transferable for evaluating their
applicability in other health conditions and situations.
Practice Implications
As instruments for measuring HL and PTHL continue to be
published, authors advise clinicians, health professionals and
researchers to evaluate available HL and PTHLmeasurements for
a conceptual and practical match with the goals of their work.
When choosing a practical match, style of administration,
purpose for measurement, their basic characteristics: domains,
methods of assignment, structure, method of scoring, validation,
strengths and limitations should be considered. It is important
to align with the topic or task under consideration and choose
the one that has been validated in a similar target population
in order to have an accurate measure of the domain being
assessed. Predictive qualities and appropriateness for assessment
of changes in HL and outcomes over time have to be taken
under consideration.
FCCHL was evaluated as the most appropriate instrument to
apply to people with diabetes since a diabetes-specific type of
instrument and the contents of its items may be more sensitive
in a diabetes clinical setting targeted at diabetes, it is a model-
based and comprehensive measure which covers all 3 levels of
HL and the evidence for the measurement properties are better
than those for the other instruments. However, his structural
validity needs to be further established, and therefore adding
DNT-15 questionnaire can be one of the options for considering
application of FCCHL in this population (90).
Based on the previous considerations FCCHL and 3-
brief SQ have the broadest measurement scopes. They are
quick, easy, and inexpensive for administration. Three-level
HL can be considered as the most useful and comprehensive
instrument to screen for inadequate HL. The limitation is
that the English version is not validated. Three-brief SQ
has many advantages in comparison to other instruments,
including that it is less likely to cause anxiety and shame.
This instrument can be considered the best for measuring
functional HL in patients with diabetes mellitus type 2 and other
chronic diseases.
Limitations
This review was subject to some limitations. The use of non-
interventional studies, the heterogeneity of studies in terms
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of samples represent important limitations for this scoping
review. Only works written in English have been considered.
Assessments of the instruments’ dimensions, strengths, and
limitations were made on the basis of our own experience
and judgment; and as such, this was a subjective review. In
order to minimize the effect of the issue of subjectivity, each
measure was analyzed by multiple authors, and any discrepancy
was addressed by all the authors and resolved through
fruitful discussion.
CONCLUSION
The ongoing development of instruments suggests that there
is still a need for comprehensive measurement across diverse
populations. Three-brief SQ has been found convenient for
use in populations with diabetes mellitus type 2 taking into
consideration the broadest measurement scope, demonstrated
good measurement properties, that has many advantages over
other instruments, and could be considered the best available
instrument to measure functional HL. FCCHL scale measures
the broader concept of HL, including the ability to retrieve,
understand, and use health-related information and could be
one of the most appropriate and comprehensive instrument for
measuring HL in people with diabetes. However, it has not been
validated in English and the future research must be directed
in this way, as well as establishing of the structural validity of
the questionnaire.
The results of the studies show that HL may be directly
related to the clinical outcome in patients with diabetes
and that each individual level of HL could act differently.
The ways in which each level of HL influences patient
behaviour about care and health outcomes should be
further explored.
So far, PTHL questionnaires (REALM/R and DNT-15) have
not found their best application in people with type 2 diabetes
mellitus and further research should certainly be aimed at
developing a specific PTHL questionnaire for people with type
2 diabetes mellitus, due to the nature of the disease itself and the
frequent use of multiple drugs in its therapy.
This works provides information to enable practitioners,
health professionals and researches to select the most appropriate
instrument available for measuring HL and PTHL in patients
with type 2 diabetes mellitus.
DATA AVAILABILITY STATEMENT
The original contributions presented in the study are included
in the article/supplementary material, further inquiries can be
directed to the corresponding author/s.
AUTHOR CONTRIBUTIONS
DK and ML contributed substantially to the conception, design
of the study, screening, and selection of the studies. ML
produced the first draft of the paper, which was extensively
redrafted by DK, with significant input from NB-S. All authors
contributed to the interpretation of data and read and approved
the final manuscript.
FUNDING
The research of DK and NB-S was partially funded by the
Ministry of Education, Science and Technological Development,
Republic of Serbia through Grant Agreement with University of
Belgrade-Faculty of Pharmacy No: 451-03-9/2021-14/200161.
ACKNOWLEDGMENTS
The authors would like to thank the professor Oliver Feeney
from the Institute of Ethics and History of Medicine, University
of Tübingen in Germany who made language corrections to
the work.
REFERENCES
1. Ministry of Education and Research. Rammeplan for Sykepleierutdanning




2. Ministry of Health and Care Services. Samhandlingsreformen. (Meld.
St. 47 2008-2009). [The coordination Reform. Report to the Storting no.
47(Norwegian Parliament)]. (2009). Available online at: https://www.
regjeringen.no/contentassets/d4f0e16ad32e4bbd8d8ab5c21445a5dc/no/pdfs/
stm200820090047000dddpdfs.pdf (accessed July 30, 2021).
3. Ministry of Health and Care Services. Nasjonal Helse- Og Omsorgsplan
(2011-2015). (Meld. St.10 2010-2011). [National Health and Care
Service Plan. Report to the Storting no. 10(Norwegian Parliament)].
(2011). Available online at: https://www.regjeringen.no/contentassets/
f17befe0cb4c48d68c744bce3673413d/no/pdfs/stm201020110016000dddpdfs.
pdf (accessed July 30, 2021).
4. Nutbeam D. Discussion Paper on Promoting, Measuring and Implementing
Health Literacy - Implications for Policy and Practice in Non-Communicable
Disease Prevention and Control (WHO GCM/NCD Working group 3.3




httpwwwwhointg (accessed July 30, 2021).
5. Kickbusch I., Pelikan JM., Apfel F, Tsouros, AD. Health Literacy. The Solid
Facts. Copenhagen: WHO (2013).
6. Berkman ND, Sheridan SL, Donahue KE., Halpern DJ, Crotty K. Low
health literacy and health outcomes: an updated systematic review. Ann
Int Med. (2011) 155:97–107. doi: 10.7326/0003-4819-155-2-201107190-
00005
7. Nakayama K., OsakaW., Togari T., Ishikawa H., Yonekura Y., Sekido A., et al.
Comprehensive health literacy in Japan is lower than in Europe: a validated
Japanese-language assessment of health literacy. BMC Public Health. (2015)
15:505. doi: 10.1186/s12889-015-1835-x
8. Paasche-OrlowMK, Parker RM, Gazmararian JA, Nielsen-Bohlman, LT, Rudd
RR. The prevalence of limited health literacy. J Gen Int Med. (2005) 20:175–
84. doi: 10.1111/j.1525-1497.2005.40245.x
9. Parker RM., Williams MV, Weiss BD, Baker DW, Davis TC, Doak CC,
et al. Health literacy-report of the council on Scientific affairs. JAMA. (1999)
281:552–7. doi: 10.1001/jama.281.6.552
Frontiers in Public Health | www.frontiersin.org 13 September 2021 | Volume 9 | Article 747807
Levic et al. Health and Pharmacotherapy Literacy in Diabetes
10. Sørensen K., Pelikan JM, Rothlin F, Ganahl K., Slonska Z., Doyle G.,
et al. Health literacy in Europe: comparative results of the European
health literacy survey (HLS-EU). Eur J Public Health. (2015) 25:1053–
8. doi: 10.1093/eurpub/ckv043
11. von Wagner C, Knight K, Steptoe A, Wardle J. Functional
health Literacy and health-promoting behaviour in a national
sample of British Adults. J Epidemiol Community Health. (2007)
61:1086–90. doi: 10.1136/jech.2006.053967
12. Williams MV, Davis T, Parker RM., Weiss, BD. The role of health literacy in
patient-physician communication. Family Med. (2002) 34:383–9.
13. Dickens C, Lambert BL, Cromwell T, Piano MR. Nurse overestimation
of patients’ health literacy. J Health Comm. (2013) 18(Suppl. 1):62–
9. doi: 10.1080/10810730.2013.825670
14. Altin SV, Finke I, Kautz-Freimuth S, Stock S. The evolution of health
literacy assessment tools: a systematic review. BMC Public Health. (2014)
14:1207. doi: 10.1186/1471-2458-14-1207
15. Nguyen TH, Paasche-Orlow MK, Kim MT, Han HR, Chan KS.
Modern measurement approaches to health literacy scale development
and refinement: overview, current uses, and next steps. J Health
Commun. (2015) 20(Suppl. 2):112–15. doi: 10.1080/10810730.2015.10
73408
16. Nguyen TH, Paasche-Orlow MK, McCormack LA. The state of the
science of health literacy measurement. Inform Serv Use. (2017) 37:189–
203. doi: 10.3233/ISU-170827
17. Sørensen K, Van den Broucke S, Fullam J, Doyle G, Pelikan J, Slonska
Z, et al. Health literacy and public health: a systematic review and
integration of definitions and models. BMC Public Health. (2012) 12:1–
13. doi: 10.1186/1471-2458-12-80
18. Simonds S.K. Health education as social policy. Health Educ
Monog. (1974) 2(1_Suppl):1–10. doi: 10.1177/1090198174002
0S102
19. Ishikawa H, Kiuchi T. Health literacy and health communication. Bio Psycho
Soc Med. (2010) 4:18. doi: 10.1186/1751-0759-4-18
20. Rudd RE, Rosenfeld L, Simonds VW. Health literacy: a new area of
research with links to communication. Atlan J Commun. (2012) 20:16–
30. doi: 10.1080/15456870.2012.637025
21. Berkman ND, Davis TC, McCormack L. Health literacy: what is it? J
Health Commun. (2010) 15(Suppl. 2):9–19. doi: 10.1080/10810730.2010.
499985
22. Parker RM. Measuring Health Literacy: What? So What? Now What. Paper
Presented at the Measures of Health Literacy: Workshop Summary. (2009).
Available online at: http://www.nationalacademies.org/hmd/~/media/Files/
Activity%20Files/PublicHealth/HealthLiteracy/Parker.pdf (accessed July 30,
2021).
23. King SR, McCaffrey DJ, Bouldin AS. Health literacy in the pharmacy
setting: defining pharmacotherapy literacy. Pharm Pract. (2011) 9:213–
20. doi: 10.4321/S1886-36552011000400006
24. Krajnovic D, Ubavic S, Bogavac-Stanojević N. Pharmacotherapy literacy and
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